BLO Cannabix Technologies Inc

Cannabix Technologies Annual General and Special Meeting Results

Cannabix Technologies Annual General and Special Meeting Results

VANCOUVER, British Columbia, June 18, 2024 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (the “Company”) announces the results of its annual general and special meeting of common shareholders held on June 18, 2024 in Vancouver. Resolutions passed at the meeting included the appointment of Saturna Group Chartered Accountants LLP as auditors for the ensuing year, an ordinary resolution to approve the adoption of the Company’s Stock Option Incentive Plan and the granting of stock options thereunder in an amount up to 15% of the total issued and outstanding shares, an ordinary resolution to approve the adoption of the Company’s Restricted Share Unit Incentive Plan and the granting of equity awards thereunder in an amount up to 5% of the total issued and outstanding shares, and the election of Dr. Raj Attariwala, Dr. Phillip Olla, Rav Mlait, Bryan Loree, and Thomas Clarke as directors.

The Company also reports the cancellation of 1,395,000 stock options exercisable at $0.80.

We seek Safe Harbor.

On behalf of the Board of Directors

“Rav Mlait”

CEO

Cannabix Technologies Inc.

For further information, contact the Company at 

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.



EN
18/06/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Cannabix Technologies Inc

 PRESS RELEASE

Cannabix Technologies Receives Notice of Allowance from USPTO for Cont...

Cannabix Technologies Receives Notice of Allowance from USPTO for Contactless Breath Analysis VANCOUVER, British Columbia, June 17, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) is pleased to report that the United States Patent and Trademark Office (USPTO) has issued a notice of allowance for patent application No. 18/1729,658 entitled, “Contact-Free Breath Analysis Device and Method” to the Company. This patent application is centered on innovations made by Cannabix and its dual mode contactless (and tradit...

 PRESS RELEASE

Omega Laboratories Delivers Marijuana Breath Test Validation Packet to...

Omega Laboratories Delivers Marijuana Breath Test Validation Packet to Cannabix Technologies Inc. - Completing Major Milestone under Strategic Partnership VANCOUVER, British Columbia, June 05, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) reports that Omega Laboratories Inc. of Ohio, USA (“Omega Laboratories” or “Omega”) a leading drug testing laboratory renowned for its comprehensive services has delivered a Validation Packet for Omega’s Laboratory Developed Test Method to test delta9 THC analytes in relation...

 PRESS RELEASE

Cannabix Technologies Enters Contract Manufacturing Agreement with Pri...

Cannabix Technologies Enters Contract Manufacturing Agreement with Price Industries for BreathLogix Devices Cannabix has developed an autonomous alcohol breathalyzer screening device for employers and a range of industries and safety settings VANCOUVER, British Columbia, May 29, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) developer of marijuana and alcohol breath devices is pleased to report that it has selected Price Industries Ltd. (“Price Electronics”) as contract manufacture for its BreathLogix alcohol...

 PRESS RELEASE

Cannabix Enters Sales Distribution Agreement with Australian Distribut...

Cannabix Enters Sales Distribution Agreement with Australian Distributor for BreathLogix Autonomous Alcohol Breathalyzer Cannabix has developed an autonomous alcohol breathalyzer screening device for employers and a range of industries and safety settings VANCOUVER, British Columbia, May 14, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) developer of marijuana and alcohol breath devices is pleased to report that it has entered into an exclusive distribution agreement (“Agreement”) with Breathalyser Sales & Se...

 PRESS RELEASE

Cannabix Technologies Receives NHTSA Approval for BreathLogix Workplac...

Cannabix Technologies Receives NHTSA Approval for BreathLogix Workplace Series Alcohol Breathalyzer Cannabix has developed an autonomous alcohol breathalyzer screening device for employers and a range of industries and safety settings VANCOUVER, British Columbia, May 05, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) reports that it has received notice from the U.S. National Highway Traffic Safety Association (NHTSA) for the approval of its BreathLogix “Workplace Series” (WS) alcohol breathalyzer. The BreathL...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch